Monthly archive | PharmaTutor

8 February 2016

Opening to work as Safety Associate Trainee at Quintiles

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. Our network of 23,000 engaged professionals in 60 countries around the globe works with an unwavering commitment to patients, safety and ethics — ensuring a higher level o f healthcare for people. For our biopharmaceutical customers, we help them navigate risk and seize opportunities in an environment where change is constant.

Read more about Easily stressed? At risk of developing high blood pressure

The tendency to take more stress during youth may increase the risk of developing high blood pressure later in life, suggests a study.Also, stressed youths who are overweight are three times more likely to develop high blood pressure, showed the findings, published online in the journal Heart.

8 February 2016

Career as Pharmacist in AMRIT Pharmacies-HLL Lifecare Limited | Mini Ratna Company of Govt. of India

HLL Lifecare Limited is a Mini Ratna Company of Govt. of India under the Ministry of Health & Family Welfare. HLL, a schedule B Public Sector Enterprise is today a multi product, multi unit organization addressing various public health challenges. The company with five manufacturing units and marketing offices throughout the country is engaged in the manufacturing and marketing of a wide range of contraceptives and healthcare products. The company has also ventured into Infrastructure Development, Procurement & Consultancy Services, setting up of Life Spring Hospitals, Women's Health Pharma Division and setting up of Diagnostic Centres.

8 February 2016

Walk in interview for Junior Research Fellow, Project Fellow, Project Assistant-I, Project Assistant-II, Project Assistant-III, Research Associate (Project) at IICT

Indian Institute of Chemical Technology, Hyderabad (CSIR-IICT) is a Premier Research Laboratory under the Council of Scientific & Industrial Research (CSIR), which is an autonomous body under the Ministry of Science & Technology, Government of India.

8 February 2016

Walk in for Junior Research Fellow, Senior Project Fellow, Project Assistant-II, Project Assistant-III in CSIR-Indian Institute of Chemical Technology, Hyderabad

Indian Institute of Chemical Technology, Hyderabad (CSIR-IICT) is a Premier Research Laboratory under the Council of Scientific & Industrial Research (CSIR), which is an autonomous body under the Ministry of Science & Technology, Government of India.

8 February 2016

Work as Executive - Regulatory Affairs at Zoetis

Zoetis is a global animal health company dedicated to supporting customers and their businesses in ever better ways. Building on 60 years of experience as Pfizer Animal Health, we deliver quality medicines and vaccines, complemented by diagnostics products and genetics tests and supported by a range of services. We are working every day to better understand and address the real-world challenges faced by those who raise and care for animals in ways they find truly relevant.

Read more about U.S. FDA approves expanded Use of Bristol-Myers Squibb’s Daklinza (daclatasvir)

Bristol-Myers Squibb’s announced that Daklinza™ (daclatasvir, 60 mg), an NS5A replication complex inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) in combination with sofosbuvir (with or without ribavirin) in genotypes 1 and 3.

Read more about Amarantus requests rare pediatric disease designation from US FDA for MANF

Amarantus Bioscience Holdings Inc. a biotechnology company focused on developing products for Regenerative Medicine, Neurology and Orphan Diseases, announced that it has requested Rare Pediatric Disease Designation (RPDD) from the US Food and Drug Administration (FDA) for treating retinitis pigmentosa (RP) with MANF(mesencephalic-astrocyte-derived neurotrophic factor). MANF was previously granted orphan drug designation (ODD) by the US FDA in December 2014.

Read more about Impax Receives Tentative FDA approval for generic version of Vytorin® (ezetimibe and simvastatin) tablets

Impax Laboratories, Inc. announced that Impax has received tentative approval from the U.S. Food and Drug Administration (FDA) for its

Read more about U.S. FDA grants breakthrough therapy designation to Immunomedics for Sacituzumab Govitecan

Immunomedics, Inc. announced that its lead investigational antibody-drug conjugate, sacituzumab govitecan, or IMMU-132, has received Breakthrough Therapy Designation from the FDA for the treatment of patients with triple-negative breast cancer (TNBC) who have failed at least 2 prior therapies for metastatic disease.

Search

February 2016

Opening to work as Safety Associate Trainee at Quintiles

RECOMMENDED POSTS

Subscribe with us

Jobs by Category